HIV Drug Interactions
Download from the AppStore
Download from Google Play
No Interaction Expected
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP)
Quality of Evidence:
Coadministration has not been studied but based on metabolism and clearance a clinically significant interaction is unlikely as reboxetine is metabolized by CYP3A4.
View all available interactions with
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP) by clicking
Last Review: May 22, 2022
Copyright © 2022 The University of Liverpool. All rights reserved.